Importantly, despite the PFS findings, a numerical trend toward improved OS was observed in patients receiving third-generation TKIs, underscoring the complexity of treatment sequencing in this subgroup.
← all excerpts
Impact of rare EGFR exon 19 insertion-deletion variants on tyrosine kinase inhibitor efficacy in non-small-cell lung cancer: a 5-year multicenter analysis.
1
—
—